Profound Historical Cash Flow

PRN Stock  CAD 11.09  0.10  0.91%   
Analysis of Profound Medical cash flow over time is an excellent tool to project Profound Medical Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 1.8 M or Capital Expenditures of 0.0 as it is a great indicator of Profound Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Profound Medical Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Profound Medical Corp is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Profound Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Profound balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Profound's non-liquid assets can be easily converted into cash.

Profound Medical Cash Flow Chart

At this time, Profound Medical's Other Cashflows From Financing Activities is very stable compared to the past year. As of the 9th of January 2025, Other Non Cash Items is likely to grow to about 1.8 M, though Change In Cash is likely to grow to (17.4 M).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from Profound Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Profound Medical's Other Cashflows From Financing Activities is very stable compared to the past year. As of the 9th of January 2025, Other Non Cash Items is likely to grow to about 1.8 M, though Change In Cash is likely to grow to (17.4 M).
 2022 2023 2024 2025 (projected)
Other Non Cash Items2.7M1.1M992.7K1.8M
Depreciation1.6M1.1M1.3M1.1M

Profound Medical cash flow statement Correlations

-0.280.2-0.51-0.110.050.230.330.30.99-0.37-0.07-0.52-0.28-0.220.7-0.210.14
-0.28-0.850.960.82-0.60.22-0.920.81-0.19-0.440.47-0.16-0.35-0.23-0.39-0.05-0.53
0.2-0.85-0.85-0.910.79-0.130.96-0.80.140.33-0.740.140.540.580.540.430.59
-0.510.96-0.850.8-0.580.11-0.910.65-0.42-0.330.490.0-0.35-0.21-0.57-0.05-0.52
-0.110.82-0.910.8-0.770.08-0.860.8-0.02-0.530.6-0.18-0.64-0.45-0.4-0.43-0.59
0.05-0.60.79-0.58-0.77-0.410.66-0.610.040.28-0.890.260.370.510.30.740.43
0.230.22-0.130.110.08-0.41-0.040.30.16-0.370.55-0.65-0.1-0.110.34-0.480.23
0.33-0.920.96-0.91-0.860.66-0.04-0.760.250.24-0.590.030.370.430.570.20.6
0.30.81-0.80.650.8-0.610.3-0.760.38-0.650.5-0.44-0.61-0.45-0.05-0.27-0.49
0.99-0.190.14-0.42-0.020.040.160.250.38-0.43-0.11-0.54-0.34-0.240.67-0.150.1
-0.37-0.440.33-0.33-0.530.28-0.370.24-0.65-0.43-0.180.380.680.06-0.380.260.13
-0.070.47-0.740.490.6-0.890.55-0.590.5-0.11-0.18-0.24-0.36-0.54-0.34-0.81-0.35
-0.52-0.160.140.0-0.180.26-0.650.03-0.44-0.540.38-0.240.40.52-0.390.31-0.41
-0.28-0.350.54-0.35-0.640.37-0.10.37-0.61-0.340.68-0.360.40.540.130.410.26
-0.22-0.230.58-0.21-0.450.51-0.110.43-0.45-0.240.06-0.540.520.540.180.5-0.08
0.7-0.390.54-0.57-0.40.30.340.57-0.050.67-0.38-0.34-0.390.130.180.020.58
-0.21-0.050.43-0.05-0.430.74-0.480.2-0.27-0.150.26-0.810.310.410.50.020.12
0.14-0.530.59-0.52-0.590.430.230.6-0.490.10.13-0.35-0.410.26-0.080.580.12
Click cells to compare fundamentals

Profound Medical Account Relationship Matchups

Profound Medical cash flow statement Accounts

202020212022202320242025 (projected)
Change In Cash69.1M(16.8M)(20.6M)(20.3M)(18.3M)(17.4M)
Stock Based Compensation3.0M7.2M4.2M3.4M3.9M2.5M
Free Cash Flow(20.9M)(23.0M)(25.8M)(22.3M)(20.1M)(21.1M)
Begin Period Cash Flow14.8M83.9M67.2M46.5M53.5M29.6M
Other Cashflows From Financing Activities11.5M6.3M7.4M2.7M3.1M5.2M
Depreciation1.5M1.9M1.6M1.1M1.3M1.1M
Other Non Cash Items890K425K2.7M1.1M992.7K1.8M
Total Cash From Operating Activities(20.6M)(22.4M)(25.8M)(22.3M)(20.1M)(21.1M)
Net Income(21.6M)(30.7M)(28.7M)(28.6M)(25.7M)(27.0M)
Total Cash From Financing Activities87.4M5.9M7.0M1.5M1.7M1.6M
End Period Cash Flow83.9M67.2M46.5M26.2M30.1M32.6M
Sale Purchase Of Stock11.5M103.7M6.4M263K302.5K287.3K
Change To Inventory(2.1M)(2.5M)(1.9M)353K317.7K333.6K
Investments(250K)(350K)(593K)(127K)(146.1K)(153.4K)
Net Borrowings(1.3M)(9.6M)(386K)6.9M6.2M6.5M
Change In Working Capital(4.6M)(877K)(5.6M)374K336.6K353.4K
Change To Account Receivables(4.0M)2.0M(1.9M)(1.4M)(1.3M)(1.3M)
Change To Operating Activities(1.7M)1.3M(13K)(2.1M)(1.9M)(1.8M)
Change To Netincome2.4M4.1M7.3M6.9M7.9M5.2M
Change To Liabilities98K281K(356K)(566K)(509.4K)(483.9K)

Pair Trading with Profound Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Profound Stock

  0.33PFE Pfizer Inc CDRPairCorr
The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.